Compare GSK plc (GSK) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Consumer Staples Select Sector SPDR Fund — how do they compare? GSK plc trades at $52.6 (market cap $101.34B), while Consumer Staples Select Sector SPDR Fund trades at $85.49. The key difference: GSK plc pays a 3.49% dividend while Consumer Staples Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| GSK | XLP | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | — |
52-Week High | $61.18 | $90.00 |
52-Week Low | $36.20 | $75.61 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
XLP trades at $85.24, up 2.19% today, but technical indicators signal a bearish trend with moving averages showing 11 sell signals versus 2 buy signals. The ETF maintains strong analyst support with 100% buy ratings from 2 analysts. Recent news highlights XLP's defensive positioning amid market uncertainty, with a 2.6% dividend yield providing income stability.
The consumer staples ETF offers defensive exposure during market volatility, supported by positive sector momentum. Key risks include sector concentration and economic sensitivity. With technical weakness but strong fundamental positioning, XLP presents a conservative play for investors seeking stability and dividend income in uncertain markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
